ProShare Advisors LLC
- SEC CIK
- 0001357955
- Latest filing
- Aug 11, 2026
DYN holding history
Dyne Therapeutics, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
DYN overviewAll 13F holders of DYNFull Q2 2026 holdings
- Shares (Q2 2026)
- 23,283
- Value
- $517.1K
- % of portfolio
- <0.1%
- Quarters held
- 13
- Since Q4 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 23,283 | $517.1K | <0.1% | −3,400−12.7% | Reduced | Holders |
| Q1 2026 | 26,683 | $483.8K | <0.1% | −2,243−7.8% | Reduced | Holders |
| Q4 2025 | 28,926 | $565.8K | <0.1% | +5,185+21.8% | Added | Holders |
| Q3 2025 | 23,741 | $300.3K | <0.1% | +251+1.1% | Added | Holders |
| Q2 2025 | 23,490 | $223.6K | <0.1% | +294+1.3% | Added | Holders |
| Q1 2025 | 23,196 | $242.6K | <0.1% | −4,848−17.3% | Reduced | Holders |
| Q4 2024 | 28,044 | $660.7K | <0.1% | +6,862+32.4% | Added | Holders |
| Q3 2024 | 21,182 | $760.9K | <0.1% | +6,012+39.6% | Added | Holders |
| Q2 2024 | 15,170 | $535.4K | <0.1% | −1,137−7.0% | Reduced | Holders |
| Q1 2024 | 16,307 | $463.0K | <0.1% | +5,028+44.6% | Added | Holders |
| Q4 2023 | 11,279 | $150.0K | <0.1% | +11,279 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −10,966−100.0% | Sold out | Holders |
| Q1 2022 | 10,966 | $105.0K | <0.1% | −2,853−20.6% | Reduced | Holders |
| Q4 2021 | 13,819 | $163.0K | <0.1% | +13,819 | New | Holders |